Ispectrum Magazine Ispectrum Magazine #10 | Page 35

Effect of tulasi on incidence and mortality. In a Korean study, prostate cancer: As of 2011, prostate cancer is the second most frequently diagnosed cancer and the sixth leading cause of cancer death in males worldwide [9]. In a study done in USA, flavonoid vicenin-2 (VCN2), an active constituent of tulasi, effectively induces anti-proliferative, anti-angiogenic and pro-apoptotic effect in prostate cancer cells. This study provided strong evidence that VCN-2 is effective against prostate cancer progression in androgen-independent prostate cancer. [10] Effect of tulasi on lung cancer: Worldwide, lung cancer is the most common cancer in terms of both results demonstrate that ethanol extracts of Ocimum sanctum (EEOS) induces apoptosis in human nonsmall cell lung carcinoma (NSCLC) A549 cells via a mitochondria caspase-dependent pathway and inhibits the in vivo growth of Lewis lung carcinoma (LLC) animal model, suggesting that EEOS can be applied to lung carcinoma as a chemo-preventive candidate [11]. 34 Effect of tulasi on other cancers: In an Indian study, tulasi leaves significantly decreased the incidence of both B[a] P-induced neoplasia and 3’MeDAB-induced hepatomas in mice [12]. In another Indian s t u d y, administration of ethanolic tulasi leaf extract reduced the incidence of N-methylN ’ - n i t r o N nitrosoguanidine (MNNG) -induced gastric carcinomas in rats [13].